The construction project for Hu Qing Yu Tang Pharmaceutical's production workshop for 2.2 billion capsules per year has commenced.

According to Shanghai Pharmaceuticals, on the morning of August 15, the construction project for the production workshop of Hangzhou Huqingyutang Pharmaceutical Co., Ltd., a subsidiary of Shanghai Pharmaceuticals, which has an annual output of 2.2 billion capsules, has commenced. It is reported that this smart workshop project for an annual output of 2.2 billion capsules is a key initiative to break through capacity bottlenecks and implement the company's strategy for major product categories.